Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001808365-25-000005

Director returned 322,021 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Knowles Julius · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-21 Returned to the company : show line 1 in the form −191,527 $17.75 $3,399,604 150,047 I
2025-11-21 Returned to the company : show line 2 in the form −130,494 $17.75 $2,316,269 102,233 I
Loading xslF345X05/form4-12182025_041201.xml…